A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(9 sites)
United States
University of Arizona Cancer Center, Tucson, Arizona Duly Health, Lisle, Illinois Wichita Urology, Wichita, Kansas Michigan Institute of Urology, Troy, Michigan Mercy Hospital, St Louis, Missouri University of Nebraska Medical Center, Omaha, Nebraska Northwell Health, Lake Success, New York Weill Cornell, New York, New York University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Last updated February 2026